Organovo - יחס שווי כולל של החברה להכנסות ONVO

Organovo Holdings, Inc. (ONVO) relies on a staff of specialized bioprinters with minimal employee turnover. The EV/Sales multiple trajectory demonstrates the asset's current dynamics, where shows the value of this parameter. The NovoGen platform for B2B testing creates growth potential, however, geopolitical fragmentation and trade barriers limit the expansion of 3D printing technologies into global markets.
ONVO (Organovo Holdings Inc): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The EV/Sales ratio determines the total enterprise value, including debt, relative to generated revenue, allowing for an assessment of the market premium paid per unit of sales. By analyzing the EV/Sales ratio, an investor can see the impact of venture capital on Organovo Holdings, Inc. (ONVO), whose capitalization is currently driven by FDA expectations and the success of 3D liver bioprinting rather than current laboratory revenues.